[Depletion therapy of chronic congestive heart failure].
D001815:Bloodletting; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology; D002712:Chlorides / Q000097:blood; D004039:Diet, Sodium-Restricted; D004071:Digitalis Glycosides / Q000494:pharmacology; D004231:Diuresis; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006333:Heart Failure / Q000601:surgery / Q000628:therapy*; D006801:Humans; D006947:Hyperkalemia; D007008:Hypokalemia; D007010:Hyponatremia; D007678:Kidney Glomerulus / Q000502:physiology; D007684:Kidney Tubules / Q000502:physiology; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds / Q000627:therapeutic use; D013148:Spironolactone / Q000037:antagonists & inhibitors; D013256:Steroids / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology; D014223:Triamterene / Q000494:pharmacology; D014498:Uracil / Q000494:pharmacology; D014667:Vasopressins / Q000037:antagonists & inhibitors; D014882:Water-Electrolyte Balance; D014966:Xanthenes / Q000494:pharmacology
D002257:Carbonic Anhydrase Inhibitors; D002712:Chlorides; D004071:Digitalis Glycosides; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds; D013256:Steroids; D013843:Thiazines; D014966:Xanthenes; D014667:Vasopressins; D013148:Spironolactone; D014498:Uracil; D005665:Furosemide; D004976:Ethacrynic Acid; D014223:Triamterene
Tratamiento depletivo de la insuficiencia cardíaca congestiva crónica.